|
|
|
|
| LEADER |
01118caa a2200325 ir4500 |
| 001 |
NSK01000240252 |
| 003 |
HR-ZaNSK |
| 005 |
20070917191349.0 |
| 008 |
990629s1998 ci ||| ||eng |
| 015 |
|
|
|a HP98-7009
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)240504
|
| 035 |
|
|
|9 (HR-ZaNSK)990629033
|
| 035 |
|
|
|a (HR-ZaNSK)000240252
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b slv
|
| 080 |
|
|
|a 547.915.03:615
|
| 080 |
|
|
|a 615:547.915.03
|
| 100 |
1 |
|
|a Ahlin, Pegi
|
| 245 |
1 |
0 |
|a Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions /
|c Pegi Ahlin, Julijana Kristl, Jelka Šmid-Korbar.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 10 jed.
|
| 504 |
|
|
|a Povzetek
|
| 650 |
|
7 |
|a Lipidi
|x Primjena
|x Farmaceutska industrija
|2 nskps
|
| 700 |
1 |
|
|a Kristl, Julijana
|
| 700 |
1 |
|
|a Šmid-Korbar, Jelka
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 48 (1998), 4 ; str. 259-267
|w nsk.(HR-ZaNSK)000054908
|
| 932 |
|
|
|a da
|b znanstveni rad
|
| 981 |
|
|
|z B1112/98
|
| 998 |
|
|
|a LUKo9906
|a sobp0002
|c ikak0009
|c vebo0204
|
| 886 |
0 |
|
|2 unimarc
|b 00888naa2 2200253 450
|